No abstract available
Keywords:
Adalimumab; Ankylosing spondylitis; Etanercept; Infliximab; Uveitis.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / immunology
-
Antirheumatic Agents / pharmacology
-
Autoimmunity / drug effects*
-
Etanercept
-
Humans
-
Immunoglobulin G* / adverse effects
-
Immunoglobulin G* / immunology
-
Immunoglobulin G* / pharmacology
-
Product Surveillance, Postmarketing
-
Receptors, Tumor Necrosis Factor* / immunology
-
Recombinant Fusion Proteins / immunology
-
Spondylitis, Ankylosing / drug therapy*
-
Spondylitis, Ankylosing / immunology
-
Tumor Necrosis Factor-alpha / immunology
-
Uveitis* / drug therapy
-
Uveitis* / etiology
-
Uveitis* / immunology
Substances
-
Antirheumatic Agents
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Recombinant Fusion Proteins
-
Tumor Necrosis Factor-alpha
-
Etanercept